Abeona Therapeutics (ABEO) Retained Earnings (2010 - 2026)

Abeona Therapeutics' Retained Earnings history runs 17 years deep, the most recent figure standing at $903.5 million for Q1 2026.

• In Q1 2026, Retained Earnings rose 209.48% year-over-year to $903.5 million; the TTM figure through Mar 2026 stood at $903.5 million (up 209.48% YoY), while the FY2025 annual figure was $138000.0, down 99.98% from the prior year.
• Retained Earnings for Q1 2026 stood at $903.5 million, up from $138000.0 in the prior quarter.
• The five-year high for Retained Earnings was $903.5 million in Q1 2026, with the low at -$825.3 million in Q1 2025.
• The 5-year median for Retained Earnings is $138000.0 (2025), against an average of $91.7 million.
• The sharpest annual moves came in 2022 and 2024: Retained Earnings soared 218.87% in 2022, then sank 811985.86% in 2024.
• Abeona Therapeutics' Retained Earnings stood at -$695.3 million in 2022, then soared by 209.9% to $764.2 million in 2023, then climbed by 12.13% to $856.8 million in 2024, then tumbled by 99.98% to $138000.0 in 2025, then surged by 654640.58% to $903.5 million in 2026.
• Business Quant data shows ABEO's Retained Earnings at $903.5 million in Q1 2026, $138000.0 in Q4 2025, and -$721.6 million in Q3 2025.